0001125376-22-000115.txt : 20220801 0001125376-22-000115.hdr.sgml : 20220801 20220801161638 ACCESSION NUMBER: 0001125376-22-000115 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20220801 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220801 DATE AS OF CHANGE: 20220801 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ENSIGN GROUP, INC CENTRAL INDEX KEY: 0001125376 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SKILLED NURSING CARE FACILITIES [8051] IRS NUMBER: 330861263 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33757 FILM NUMBER: 221124961 BUSINESS ADDRESS: STREET 1: 29222 RANCHO VIEJO RD. STREET 2: SUITE 127 CITY: SAN JUAN CAPISTRANO STATE: CA ZIP: 92675 BUSINESS PHONE: (949) 487-9500 MAIL ADDRESS: STREET 1: 29222 RANCHO VIEJO RD. STREET 2: SUITE 127 CITY: SAN JUAN CAPISTRANO STATE: CA ZIP: 92675 FORMER COMPANY: FORMER CONFORMED NAME: ENSIGN GROUP INC DATE OF NAME CHANGE: 20000930 8-K 1 ensg-20220801.htm 8-K ensg-20220801
0001125376false00011253762022-08-012022-08-01

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 1, 2022
The Ensign Group, Inc.
(Exact name of registrant as specified in its charter)
     
Delaware 001-33757 33-0861263
     
(State or other jurisdiction
of incorporation)
 (Commission File Number) (IRS Employer Identification No.)
29222 Rancho Viejo Road, Suite 127, 
San Juan Capistrano,CA92675
   
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (949) 487-9500
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.001 per shareENSGNasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.




Item 2.02. Results of Operations and Financial Condition.
On August 1, 2022 The Ensign Group, Inc. (the Company) issued a press release reporting the financial results of the Company for its second quarter ended June 30, 2022. A copy of the press release is attached to this Current Report as Exhibit 99.1.
The press release includes “non-GAAP financial measures.” Specifically, the press release refers to EBITDA, Adjusted EBITDA, Adjusted EBITDAR and Funds from Operations (FFO) for our real estate segment. EBITDA, Adjusted EBITDA, Adjusted EBITDAR and FFO are supplemental non-GAAP financial measures. Regulation G, Conditions for Use of Non-GAAP Financial Measures, and other provisions of the Securities Exchange Act of 1934, as amended, define and prescribe the conditions for use of certain non-GAAP financial information. EBITDA consists of net income before (a) other expense, net, (b) provisions for income taxes and (c) depreciation and amortization. Adjusted EBITDA consists of net income before (a) other expense, net, (b) provisions for income taxes, (c) depreciation and amortization, (d) stock-based compensation expense; (e) results of operations not at full capacity, excluding depreciation, interest and income taxes, (f) acquisition related costs, new systems implementation costs and other costs, (g) legal finding and (h) gain on sale of assets. Adjusted EBITDAR consists of net income before (a) other expense, net, (b) provisions for income taxes, (c) depreciation and amortization, (d) rent-cost of services, (e) stock-based compensation expense; (f) results of operations not at full capacity, excluding rent, depreciation, interest and income taxes, (g) acquisition related costs acquisition related costs, new systems implementation costs and other costs, (h) legal finding and (i) gain on sale of assets. Funds from Operations (FFO) for our real estate segment consists of segment income, excluding depreciation and amortization related to real estate, gains or losses from sales of real estate, insurance recoveries related to real estate and impairment of depreciable real estate assets. The company believes that the presentation of EBITDA, adjusted EBITDA, FFO, adjusted net income and adjusted earnings per share provides important supplemental information to management and investors to evaluate the company’s operating performance. Adjusted EBITDAR is a financial valuation measure that is not specified in GAAP. This measure is not displayed as a performance measure as it excludes rent expense, which is a normal and recurring operating expense. The company believes disclosure of adjusted net income, adjusted net income per share, FFO, EBITDA, adjusted EBITDA and adjusted EBITDAR has substance because the excluded revenues and expenses are infrequent in nature and are variable in nature, or do not represent current revenues or cash expenditures. A material limitation associated with the use of these measures as compared to the GAAP measures of net income and diluted earnings per share is that they may not be comparable with the calculation of net income and diluted earnings per share for other companies in the company's industry. These non-GAAP financial measures should not be relied upon to the exclusion of GAAP financial measures. For further information regarding why the company believes that this non-GAAP measures provide useful information to investors, the specific manner in which management uses these measures, and some of the limitations associated with the use of these measures, please refer to the company's periodic filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Report on Form 10-Q. The company’s periodic filings are available on the SEC's website at www.sec.gov or under the "Financial Information" link of the Investor Relations section on Ensign’s website at http://www.ensigngroup.net.

Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
   
Exhibit No. Description
   
 
Press Release of the Company dated August 1, 2022
104Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.





SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
Dated: August 1, 2022
THE ENSIGN GROUP, INC. 
 By:  /s/ Suzanne D. Snapper   
  Suzanne D. Snapper  
  Chief Financial Officer, Executive Vice President and Director (principal financial officer and accounting officer and duly authorized officer) 
 


EX-99.1 2 q22022pressrelease.htm EX-99.1 Document


ensigngrouplogoa02a01a34.gif

The Ensign Group Reports Second Quarter 2022 Results

Conference Call and Webcast scheduled for tomorrow, August 2, 2022 at 10:00 am PT

SAN JUAN CAPISTRANO, California – August 1, 2022 – The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign(TM) group of companies, which provide post-acute healthcare services and invest in the long-term healthcare industry, primarily in skilled nursing and senior living facilities, announced operating results for the second quarter of 2022, reporting GAAP diluted earnings per share and adjusted earnings per share(1) of $1.01 for the quarter ended June 30, 2022.

Highlights Include:

GAAP diluted earnings per share and adjusted diluted earnings per share for the quarter was $1.01, representing an increase of 16.1% and 13.5%(1), respectively, over the prior year quarter.

Consolidated GAAP revenues and adjusted revenues(1) for the quarter were $732.5 million, an increase of 14.7% over the prior year quarter.

Total skilled services(2) revenue was $702.5 million for the quarter, an increase of 14.6% over the prior year quarter and total skilled services(2) segment income increased to $102.3 million or 13.6% compared to prior year quarter.

Same store and transitioning occupancy increased by 1.8% and 6.4%, respectively, over prior year quarter and increased by 0.7% and 1.8%, respectively, both sequentially over the first quarter.

Same store and transitioning managed care revenue improved by 6.0% and 29.1%, respectively, over the prior year quarter and same store and transitioning managed care days increased by 4.1% and 26.0%, respectively, over the prior year quarter.

Combined Same store and transitioning Medicare revenue and days improved by 5.4% and 4.7%, respectively from prior year quarter.

Standard Bearer(2) revenue was $17.6 million for the quarter, an increase of 23.8% from prior year quarter and FFO was $12.1 million for the quarter.

GAAP net income was $57.7 million and adjusted net income(1) was $57.4 million, an increase of 16.7% and 12.9%, respectively, over the prior year quarter.

(1) See "Reconciliation of GAAP to Non-GAAP Financial Information".
(2) Our Skilled Services and Standard Bearer Segments are defined and outlined in Note 8 on Form 10-Q.

Quarterly Results

“Our local teams have once again posted impressive clinical and financial results, and continue to build remarkable momentum in each market across our portfolio,” said Barry Port, Ensign’s Chief Executive Officer. “Our success is entirely due to the efforts and commitment of our teams and caregivers, and our most important focus is to support those that care for our patients every day. As our operators strive to be the examples of excellence in every market they serve, they also recognize the opportunities to return to certain operational fundamentals, which have been challenging to maintain in the midst of the disruption in the labor markets and the continued lingering impact of the pandemic. By applying proven cultural and operational principles, our local leaders continue to retain and recruit high caliber teams, which then go on to achieve clinical and financial success in the face of external challenges. As a result of those efforts, we are pleased to continue to see impressive improvement in staffing and turnover across almost every geography we serve. We are confident that by being true to our cultural values and proven operating principles, that the near and long-term future is brighter than ever,” Port added.





Port noted that during the quarter the Company experienced continued improvement in occupancies, skilled revenue and managed care revenue, and reported that its operators achieved sequential growth in overall occupancy for the sixth consecutive quarter. Ensign also reported that its affiliated operations experienced strong quarter over quarter growth in skilled mix days, with same store and transitioning operations combining for a skilled mix days of 31.6% and same store reaching a skilled mix days of 32.6%. In addition, the Company saw continued improvement in occupancies, with same store and transitioning occupancy increasing by 1.8% and 6.4%, respectively, over the prior year quarter. “We are excited about this continued strength in our occupancies and skilled mix, and remain confident that we are on a path that will lead to sustained long-term growth. Each operation is constantly looking ahead and forming a customized strategy to thrive even in the face of an evolving reimbursement environment, staffing challenges and inflationary pressures. Our operating model allows each operator to adjust to the needs of their local markets, including methods for attracting new healthcare professionals into our workforce and retaining and developing existing staff,” Port said.

“Given the strength we see in occupancies and the improvement we see in labor, we are raising our annual 2022 earnings guidance to $4.05 to $4.15 per diluted share and annual revenue guidance to $2.96 billion to $3.0 billion. The new midpoint of this 2022 earnings guidance represents an increase of 13% over our 2021 results and is 31% higher than our 2020 results.

Chad Keetch, Ensign’s Chief Investment Officer and Executive Vice President pointed to the Company’s recent additions and noted that the organization is poised to continue to take advantage of an improving acquisition environment. “We are very excited about the eleven new operations we added during the quarter and since and look forward to seeing them contribute to the success of their clusters and their markets as they implement proven Ensign operational and clinical principles. Standard Bearer Healthcare REIT, Inc., our captive real estate company, was pleased to add six assets to its portfolio during the quarter and since, all of which are operated by Ensign affiliates. We have been extra diligent to ensure that each new addition had the full support of a healthy market, a proven leadership plan and a clear pathway to strong clinical and financial performance,” Keetch said.

Port continued, “We again remind you that our model is built for times like these. Our 23-year track record has demonstrated the locally-driven leadership model and has allowed us to produce consistent results through a variety of challenges, including the most recent pandemic. Regardless of COVID trends, government waivers or political climates, we are confident in our ability to make operational adjustments, take advantage of an attractive acquisition environment and lean on our experienced leadership both in our Service Center and in the field, to continue our long-term path of performance.”

Speaking to the Company’s financial health, Chief Financial Officer, Suzanne Snapper also reported that the company’s liquidity remains strong with approximately $285.6 million of cash on hand and $593.3 million of available capacity under its line-of-credit, which was increased by $250.0 million to $600.0 million in April 2022.

Ms. Snapper also indicated that, “Management’s guidance is based on diluted weighted average common shares outstanding of approximately 57.2 million and a 25% tax rate. In addition, the guidance assumes, among other things, normalized health insurance costs, management’s current expectations regarding Medicare and Medicaid reimbursement rates, net of provider taxes, and recovery of the COVID-19 pandemic. It also excludes one-time charges, acquisition-related costs and amortization costs related to intangible assets acquired and share-based compensation.”

A discussion of the company's use of non-GAAP financial measures is set forth below. A reconciliation of net income to EBITDA, adjusted EBITDAR, adjusted EBITDA, FFO for our real estate segment, as well as, a reconciliation of GAAP earnings per share, net income to adjusted net income and adjusted net earnings per share appear in the financial data portion of this release. More complete information is contained in the company’s Quarterly Report on Form 10-Q for the period ended June 30, 2022 which is expected to be filed with the SEC today and can be viewed on the company’s website at http://www.ensigngroup.net.

Growth and Real Estate Highlights

The Company’s affiliates continued their acquisition growth efforts in some of its most mature markets during the quarter.

The recent acquisitions include the following operations:

Sea Cliff Assisted Living, an 84-bed senior living facility located in Huntington Beach, California;

The Grove Assisted Living, a 90-bed senior living facility located in Riverside, California; and

Redmond Heights Senior Living, a 97-bed senior living facility located in Redmond, Washington.

Pleasant Valley Healthcare and Rehabilitation Center, a 124-bed skilled nursing facility located in Garland, Texas;

Millbrook Healthcare and Rehabilitation Center, a 124-bed skilled nursing facility in Lancaster, Texas;

McKinney Healthcare and Rehabilitation Center, a 125-bed skilled nursing facility in McKinney, Texas; and




Park Manor Bee Cave, a 140-bed skilled nursing facility in Bee Cave, Texas.

Henderson Health and Rehabilitation, a skilled nursing facility with 266 skilled nursing beds in Henderson, Nevada

The Eden of Las Colinas, a 118-bed skilled nursing facility, located in Irving, Texas;

Villa Maria Post Acute and Rehabilitation, a 65-bed skilled nursing facility, Villa Maria Wellness Living, a 31-bed assisted living facility and Tucson Recovery at Villa Maria, a 30-bed behavioral health unit, each located in Tucson, Arizona; and

Park Manor of McKinney, a skilled nursing facility with 138 skilled nursing beds in McKinney, Texas.

Several of these acquisitions involve senior living operations that were part of the spin out of certain assets to The Pennant Group, Inc. After several years of operating independent of Ensign, both Pennant and Ensign determined that due to the nature of these buildings, most of which are part of healthcare campuses that include Ensign affiliated skilled nursing operations, the operational efficiencies and other strategic advantages justified returning these operations to Ensign.

Standard Bearer also announced the following acquisitions during the quarter and since:
Premier Care Center of Palm Springs, a 99-bed skilled nursing facility located in Palm Springs, California, which is operated by an independent operating subsidiary of Ensign;

Brookside Healthcare Center, a 97-bed skilled nursing facility located in Redlands, California, which is operated by an independent operating subsidiary of Ensign;

Broadway Villa Post Acute, a 138-bed skilled nursing facility located in Sonoma, California;

the real estate and operations of The Eden of Las Colinas, a 118-bed skilled nursing facility, located in Irving, Texas;

the real estate and operations of Villa Maria Post Acute and Rehabilitation, a 65-bed skilled nursing facility, Villa Maria Wellness Living, a 31-bed assisted living facility and Tucson Recovery at Villa Maria, a 30-bed behavioral health unit, each located in Tucson, Arizona;

the real estate and operations of Park Manor of McKinney, a skilled nursing facility with 138 skilled nursing beds in McKinney, Texas.

“We are extremely excited to purchase these real estate assets,” Keetch said. “Three of these operations are ones Ensign has operated for a number of years. Each of these operations have been strong contributors to our operational success, and will now add meaningful value to our growing real estate portfolio,” he added.

Keetch noted that that the growth this quarter and since, which included six real estate purchases by Standard Bearer and seven new leases by an Ensign affiliated operator, demonstrates Ensign’s overall strategy will continue to include both leasing new operations, acquiring the real estate in new operations and acquiring real estate in existing operations. Keetch also said that these acquisitions continue to showcase one of Standard Bearer’s primary strategies, which is to capture the upside created by Ensign operators in properties that have historically been subject to a long-term lease. “We value the relationships we’ve shared with the owners of these assets and are pleased that we were able to help them achieve their estate planning goals while simultaneously growing Standard Bearer. We are always excited to purchase properties we know so well and have operated for years and look forward to more deals like this in the future. We also continue to evaluate new opportunities that would include operations that will be run by Ensign and some that could be operated by third-parties," said Keetch.

In total, these additions bring Ensign's growing portfolio to 259 healthcare operations, 26 of which also include senior living operations, across thirteen states. Ensign now owns 106 real estate assets, 77 of which it operates. Keetch also noted that the pipeline for Ensign’s typical turnaround opportunities is strong and improving, including leases and real estate purchases. “We have several more deals that we expect to close this fall, and expect to continue the pattern of growth we’ve shown so far this year. With our newly minted credit agreement and a healthy amount of cash on hand, we have a lot of dry powder to grow and expect some of the industry-wide changes to lead to even more opportunities in the near- and long-term future,” he added.

The Company continues to provide additional disclosure on Standard Bearer, which is comprised of 101 properties owned by the Company and leased to 73 affiliated skilled nursing and senior living operations and 29 senior living operations that are leased to The Pennant Group, Inc. Keetch noted that each of these properties are subject to triple-net, long-term leases and generated rental revenue of $17.6 million for the quarter, of which $13.9 million was derived from Ensign affiliated operations. Also, for the quarter, Ensign reported that Standard Bearer produced $12.1 million in FFO.

The Company paid a quarterly cash dividend of $0.055 per share of Ensign common stock. Keetch noted that the company’s liquidity remains strong and that the Company plans to continue its 20-year history of paying dividends into the future. The Company also repurchased 271,000 of its common stock for approximately $20.0 million and completed its stock repurchase programs entered into earlier this year.



Conference Call

A live webcast will be held Tuesday, August 2, 2022 at 10:00 a.m. Pacific time (1:00 p.m. Eastern time) to discuss Ensign’s second quarter of 2022 financial results. To listen to the webcast, or to view any financial or statistical information required by SEC Regulation G, please visit the Investors Relations section of Ensign’s website at http://investor.ensigngroup.net. The webcast will be recorded, and will be available for replay via the website until 5:00 p.m. Pacific time on Friday, September 2, 2022.

About Ensign™

The Ensign Group, Inc.'s independent operating subsidiaries provide a broad spectrum of skilled nursing and senior living services, physical, occupational and speech therapies and other rehabilitative and healthcare services at 259 healthcare facilities in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington and Wisconsin. As part of its investment strategy, the Company also acquire, lease and own healthcare real estate to service the post-acute care continuum through acquisition and investment opportunities in healthcare properties. Ensign’s new business venture operating subsidiaries also offer several other post-acute-related services, including mobile x-ray, non-emergency transportation services and other consulting services also across several states. Each of these operations is operated by a separate, independent operating subsidiary that has its own management, employees and assets. References herein to the consolidated "company" and "its" assets and activities, as well as the use of the terms "we," "us," "its" and similar verbiage, are not meant to imply that The Ensign Group, Inc. has direct operating assets, employees or revenue, or that any of the facilities, the Service Center, Standard Bearer or the captive insurance subsidiary are operated by the same entity. More information about Ensign is available at http://www.ensigngroup.net.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

This press release contains, and the related conference call and webcast will include, forward-looking statements that are based on management’s current expectations, assumptions and beliefs about its business, financial performance, operating results, the industry in which it operates and other future events. Forward-looking statements can often be identified by words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "could," "potential," "continue," "ongoing," similar expressions, and variations or negatives of these words. These forward-looking statements include, but are not limited to, statements regarding growth prospects, future operating and financial performance, and acquisition activities. They are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to materially and adversely differ from those expressed in any forward-looking statement.

These risks and uncertainties relate to the company’s business, its industry and its common stock and include: reduced prices and reimbursement rates for its services; its ability to acquire, develop, manage or improve operations, its ability to manage its increasing borrowing costs as it incurs additional indebtedness to fund the acquisition and development of operations; its ability to access capital on a cost-effective basis to continue to successfully implement its growth strategy; its operating margins and profitability could suffer if it is unable to grow and manage effectively its increasing number of operations; competition from other companies in the acquisition, development and operation of facilities; its ability to defend claims and lawsuits, including professional liability claims alleging that our services resulted in personal injury, and other regulatory-related claims; and the application of existing or proposed government regulations, or the adoption of new laws and regulations, that could limit its business operations, require it to incur significant expenditures or limit its ability to relocate its operations if necessary. Additionally, our business and operations in 2022 continue to be impacted by the COVID-19 pandemic. Because of the unprecedented nature of the pandemic, we are unable to predict the full extent and duration of the financial impact of COVID-19 on our business, financial condition and results of operations. Therefore, our actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various factors. Readers should not place undue reliance on any forward-looking statements and are encouraged to review the company’s periodic filings with the Securities and Exchange Commission, including its Form 10-K and Form 10-Q, for a more complete discussion of the risks and other factors that could affect Ensign’s business, prospects and any forward-looking statements. Except as required by the federal securities laws, Ensign does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changing circumstances or any other reason after the date of this press release.

Contact Information
Investor/Media Relations, The Ensign Group, Inc., (949) 487-9500, ir@ensigngroup.net.

SOURCE: The Ensign Group, Inc.





THE ENSIGN GROUP, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME

Three Months Ended June 30,Six Months Ended June 30,
2022202120222021
(In thousands, except per share data)
REVENUE
Service revenue$728,347 $634,609 $1,437,503 $1,257,885 
Rental revenue4,139 3,927 8,428 7,904 
TOTAL REVENUE$732,486 $638,536 $1,445,931 $1,265,789 
Expense:
Cost of services563,641 488,524 1,119,282 970,710 
Rent—cost of services 37,228 34,455 72,990 67,911 
General and administrative expense38,527 36,908 76,783 71,181 
Depreciation and amortization14,858 13,795 29,534 27,454 
TOTAL EXPENSES654,254 573,682 1,298,589 1,137,256 
Income from operations78,232 64,854 147,342 128,533 
Other (expense) income:
Interest expense(2,688)(1,634)(4,756)(3,275)
Other (expense) income(2,587)1,121 (3,403)1,869 
Other expense, net(5,275)(513)(8,159)(1,406)
Income before provision for income taxes72,957 64,341 139,183 127,127 
Provision for income taxes15,154 13,758 31,292 26,707 
NET INCOME57,803 50,583 107,891 100,420 
Less: net (loss) income attributable to noncontrolling interests112 1,158 (140)1,789 
Net income attributable to The Ensign Group, Inc.$57,691 $49,425 $108,031 $98,631 
NET INCOME PER SHARE ATTRIBUTABLE TO THE ENSIGN GROUP INC.
Basic $1.05 $0.91 $1.97 $1.82 
Diluted$1.01 $0.87 $1.90 $1.73 
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING
Basic54,906 54,468 54,788 54,331 
Diluted56,853 56,997 56,862 56,945 




THE ENSIGN GROUP, INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

June 30, 2022December 31, 2021
(In thousands)
ASSETS
Current assets:
Cash and cash equivalents$285,580 $262,201 
Accounts receivable—less allowance for doubtful accounts of $7,827 and $11,213 at June 30, 2022 and December 31, 2021, respectively339,001 328,731 
Investments—current8,991 13,763 
Prepaid income taxes16,336 5,452 
Prepaid expenses and other current assets32,774 29,562 
Total current assets682,682 639,709 
Property and equipment, net908,228 888,434 
Right-of-use assets 1,305,009 1,138,872 
Insurance subsidiary deposits and investments40,077 36,567 
Escrow deposits15,571 — 
Deferred tax assets32,883 33,147 
Restricted and other assets 57,010 47,046 
Intangible assets, net 2,535 2,652 
Goodwill 76,869 60,469 
Other indefinite-lived intangibles 3,807 3,727 
TOTAL ASSETS$3,124,671 $2,850,623 
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable$60,414 $58,116 
Accrued wages and related liabilities273,276 278,770 
Lease liabilities—current 58,769 52,181 
Accrued self-insurance liabilities—current49,728 40,831 
Other accrued liabilities 85,793 89,410 
Current maturities of long-term debt3,944 3,760 
Total current liabilities531,924 523,068 
Long-term debt—less current maturities151,105 152,883 
Long-term lease liabilities—less current portion 1,216,335 1,056,515 
Accrued self-insurance liabilities—less current portion76,793 69,308 
Other long-term liabilities27,821 27,135 
Total equity1,120,693 1,021,714 
TOTAL LIABILITIES AND EQUITY$3,124,671 $2,850,623 



THE ENSIGN GROUP, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

The following table presents selected data from our condensed consolidated statements of cash flows for the periods presented:

Six Months Ended June 30,
20222021
NET CASH PROVIDED BY/(USED IN):(In thousands)
Operating activities$129,813 $108,397 
Investing activities(76,596)(40,862)
Financing activities(29,838)(105,686)
Net increase/(decrease) in cash and cash equivalents23,379 (38,151)
Cash and cash equivalents beginning of period262,201 236,562 
Cash and cash equivalents at end of period$285,580 $198,411 




THE ENSIGN GROUP, INC.
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION
(In thousands, except per share data)

RECONCILIATION OF GAAP TO NON-GAAP NET INCOME

The following table reconciles net income to Non-GAAP net income for the periods presented:

Three Months Ended June 30,Six Months Ended June 30,
2022202120222021
Net income attributable to The Ensign Group, Inc.$57,691 $49,425 $108,031 $98,631 
Non-GAAP adjustments
Stock-based compensation expense(a)5,616 4,633 10,783 8,687 
Results related to operations not at full capacity(b)— — — 657 
Legal finding(c)— — 3,353 — 
Cost of services - gain on sale of assets (2,567)— (2,567)(540)
Interest expense - write off deferred financing fees(d)566 — 566 — 
Acquisition related costs, new systems implementation costs and other costs(e)69 399 240 435 
Depreciation and amortization - patient base(f)71 15 127 27 
Provision for income taxes on Non-GAAP adjustments(g)(4,024)(3,589)(6,698)(7,390)
Non-GAAP income $57,422 $50,883 $113,835 $100,507 
Average number of diluted shares outstanding56,853 56,997 56,862 56,945 
Diluted Earnings Per Share
Net income$1.01 $0.87 $1.90 $1.73 
Adjusted Diluted Earnings Per Share
Net Income$1.01 $0.89 $2.00 $1.76 
Footnotes:
(a) Represents stock-based compensation expense incurred.
Three Months Ended June 30,Six Months Ended June 30,
2022202120222021
Cost of services$3,670 $2,871 $7,045 $5,371 
General and administrative1,946 1,762 3,738 3,316 
Total Non-GAAP adjustment$5,616 $4,633 $10,783 $8,687 
(b) Represents results to operations not at full capacity
Three Months Ended June 30,Six Months Ended June 30,
2022202120222021
Revenue$— $— $— $(456)
Cost of services— — — 1,040 
Rent— — — 38 
Depreciation and amortization— — — 35 
Total Non-GAAP adjustment$ $ $ $657 
(c) Legal finding against our non-emergent transportation subsidiary.
(d) Represents the write off of deferred financing fees associated with the amendment of the credit facility.
(e) Represents costs incurred to acquire operations and system implementation costs that are not capitalizable. Other costs includes legal, transactional and other costs incurred related to the formation of Standard Bearer and other real estate related activities.
(f) Included in depreciation and amortization are amortization expenses related to patient base intangible assets at newly acquired skilled nursing and senior living facilities.
(g) Represents an adjustment to the provision for income tax to our historical year to date effective tax rate of 25.0%.



THE ENSIGN GROUP, INC.
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION
(In thousands)

The table below reconciles net income to EBITDA, Adjusted EBITDA and Adjusted EBITDAR for the periods presented:
Three Months Ended June 30,Six Months Ended June 30,
2022202120222021
Condensed Consolidated Statements of Income Data:
Net income $57,803 $50,583 $107,891 $100,420 
Less: net (loss) income attributable to noncontrolling interests112 1,158 (140)1,789 
Add: Other expense, net5,275 513 8,159 1,406 
Provision for income taxes15,154 13,758 31,292 26,707 
Depreciation and amortization14,858 13,795 29,534 27,454 
EBITDA$92,978 $77,491 $177,016 $154,198 
Adjustments to EBITDA:
Stock-based compensation expense5,616 4,633 10,783 8,687 
Legal finding(a) — — 3,353 — 
Gain on sale of assets(2,567)— (2,567)(540)
Results related to operations not at full capacity— — — 584 
Acquisition related costs, new systems implementation costs and other costs(b)69 399 240 435 
Rent related to items above— — — 38 
Adjusted EBITDA$96,096 $82,523 $188,825 $163,402 
Rent—cost of services37,228 34,455 72,990 67,911 
Less: rent related to items above— — — (38)
Adjusted rent 37,228 34,455 72,990 67,873 
Adjusted EBITDAR $133,324 $261,815 
(a) Legal finding against our non-emergent transportation subsidiary.
(b) Costs incurred to acquire operations and system implementation costs that are not capitalizable. Other costs includes legal, transactional and other costs
incurred related to the formation of Standard Bearer and other real estate related activities.


THE ENSIGN GROUP, INC.
UNAUDITED SELECT PERFORMANCE INDICATORS

The following tables summarize our selected performance indicators for our skilled services segment along with other statistics, for each of the dates or periods indicated:
Three Months Ended June 30,
 20222021Change% Change
TOTAL FACILITY RESULTS: (Dollars in thousands)
Skilled services revenue$702,478 $612,882 $89,596 14.6 %
Number of facilities at period end215 206 4.4 %
Number of campuses at period end*25 25 — — %
Actual patient days1,745,027 1,599,707 145,320 9.1 %
Occupancy percentage — Operational beds75.2 %72.7 %2.5 %
Skilled mix by nursing days31.1 %30.9 %0.2 %
Skilled mix by nursing revenue50.9 %51.4 %(0.5)%



Three Months Ended June 30,
 20222021Change% Change
SAME FACILITY RESULTS:(1)
(Dollars in thousands)
Skilled services revenue$551,548 $511,921 $39,627 7.7 %
Number of facilities at period end167 167 — — %
Number of campuses at period end*20 20 — — %
Actual patient days1,348,252 1,315,775 32,477 2.5 %
Occupancy percentage — Operational beds75.8 %74.0 %1.8 %
Skilled mix by nursing days32.6 %32.3 %0.3 %
Skilled mix by nursing revenue52.6 %52.9 %(0.3)%
Three Months Ended June 30,
20222021Change% Change
TRANSITIONING FACILITY RESULTS:(2)
(Dollars in thousands)
Skilled services revenue$94,881 $80,487 $14,394 17.9 %
Number of facilities at period end27 27 — — %
Number of campuses at period end*— — %
Actual patient days248,767 226,729 22,038 9.7 %
Occupancy percentage — Operational beds74.4 %68.0 %6.4 %
Skilled mix by nursing days26.4 %24.9 %1.5 %
Skilled mix by nursing revenue45.0 %44.4 %0.6 %
Three Months Ended June 30,
20222021Change% Change
RECENTLY ACQUIRED FACILITY RESULTS:(3)
(Dollars in thousands)
Skilled services revenue$56,049 $20,474 $35,575 NM
Number of facilities at period end21 12 NM
Number of campuses at period end*— — — NM
Actual patient days148,008 57,203 90,805 NM
Occupancy percentage — Operational beds71.2 %64.9 %NM
Skilled mix by nursing days25.2 %21.8 %NM
Skilled mix by nursing revenue44.2 %41.3 %NM
* Campus represents a facility that offers both skilled nursing and senior living services. Revenue and expenses related to skilled nursing and senior living services have been allocated and recorded in the respective operating segment. In the second quarter of 2022, we converted two skilled nursing facilities into campuses.
(1)Same Facility results represent all facilities purchased prior to January 1, 2019.
(2)Transitioning Facility results represent all facilities purchased from January 1, 2019 to December 31, 2020.
(3)Recently Acquired Facility (Acquisitions) results represent all facilities purchased on or subsequent to January 1, 2021.

Six Months Ended June 30,
 20222021Change% Change
TOTAL FACILITY RESULTS:(Dollars in thousands)
Skilled services revenue$1,389,249 $1,213,918 $175,331 14.4 %
Number of facilities at period end215 206 4.4 %
Number of campuses at period end*25 25 — — %
Actual patient days3,440,991 3,109,307 331,684 10.7 %
Occupancy percentage — Operational beds74.7 %71.9 %2.8 %
Skilled mix by nursing days32.4 %32.6 %(0.2)%
Skilled mix by nursing revenue52.6 %53.5 %(0.9)%



Six Months Ended June 30,
 20222021Change% Change
SAME FACILITY RESULTS:(1)
(Dollars in thousands)
Skilled services revenue$1,096,733 $1,022,580 $74,153 7.3 %
Number of facilities at period end167 167 — — %
Number of campuses at period end*20 20 — — %
Actual patient days2,669,934 2,584,029 85,905 3.3 %
Occupancy percentage — Operational beds75.4 %73.1 %2.3 %
Skilled mix by nursing days33.9 %33.7 %0.2 %
Skilled mix by nursing revenue54.1 %54.6 %(0.5)%
Six Months Ended June 30,
20222021Change% Change
TRANSITIONING FACILITY RESULTS:(2)
(Dollars in thousands)
Skilled services revenue$186,677 $160,887 $25,790 16.0 %
Number of facilities at period end27 27 — — %
Number of campuses at period end*— — %
Actual patient days488,679 445,552 43,127 9.7 %
Occupancy percentage — Operational beds73.5 %67.2 %6.3 %
Skilled mix by nursing days27.8 %26.8 %1.0 %
Skilled mix by nursing revenue47.7 %47.1 %0.6 %
Six Months Ended June 30,
20222021Change% Change
RECENTLY ACQUIRED FACILITY RESULTS:(3)
(Dollars in thousands)
Skilled services revenue$105,839 $30,451 $75,388 NM
Number of facilities at period end21 12 NM
Number of campuses at period end*— — — NM
Actual patient days282,378 79,726 202,652 NM
Occupancy percentage — Operational beds70.2 %64.4 %NM
Skilled mix by nursing days26.2 %26.7 %NM
Skilled mix by nursing revenue45.7 %49.1 %NM
* Campus represents a facility that offers both skilled nursing and senior living services. Revenue and expenses related to skilled nursing and senior living services have been allocated and recorded in the respective operating segment. In the first half of 2022, we converted three skilled nursing facilities into campuses.
(1)Same Facility results represent all facilities purchased prior to January 1, 2019.
(2)Transitioning Facility results represent all facilities purchased from January 1, 2019 to December 31, 2020.
(3)Recently Acquired Facility (Acquisitions) results represent all facilities purchased on or subsequent to January 1, 2021.




THE ENSIGN GROUP, INC.
SKILLED NURSING AVERAGE DAILY REVENUE RATES AND
PERCENT OF SKILLED NURSING REVENUE AND DAYS BY PAYOR
(Unaudited)

The following table reflects the change in skilled nursing average daily revenue rates by payor source, excluding services that are not covered by the daily rate(1):
Three Months Ended June 30,
 Same FacilityTransitioningAcquisitionsTotal
 20222021202220212022202120222021
SKILLED NURSING AVERAGE DAILY REVENUE RATES
Medicare$689.53 $685.30 $678.08 $670.99 $698.18 $717.04 $688.61 $684.33 
Managed care514.98 505.71 473.64 462.43 512.97 516.40 509.64 501.06 
Other skilled579.53 538.16 461.06 424.35 488.46 538.34 560.62 530.17 
Total skilled revenue595.65 582.66 565.76 560.31 586.80 622.36 591.41 581.11 
Medicaid261.00 249.46 251.78 232.53 249.28 245.07 258.48 246.65 
Private and other payors250.25 238.06 228.39 232.50 250.88 271.47 246.87 238.06 
Total skilled nursing revenue$368.82 $355.86 $332.09 $314.18 $334.34 $329.34 $360.65 $349.00 
(1) These rates exclude additional Federal Medical Assistance Percentage (FMAP) and include sequestration reversal of 1% in 2022 and 2% in 2021.

Six Months Ended June 30,
 Same FacilityTransitioningAcquisitionsTotal
 20222021202220212022202120222021
SKILLED NURSING AVERAGE DAILY REVENUE RATES
Medicare$691.85 $687.54 $687.25 $679.73 $690.41 $755.33 $691.10 $688.12 
Managed care511.59 505.69 473.98 459.08 509.64 523.55 506.90 500.60 
Other skilled579.17 540.72 462.30 403.54 490.07 541.48 561.53 531.74 
Total skilled revenue597.07 588.07 577.72 569.60 587.31 647.77 594.06 587.15 
Medicaid260.73 250.79 246.75 234.03 246.33 243.36 257.26 247.95 
Private and other payors252.02 239.22 231.51 235.10 254.79 263.40 249.02 238.98 
Total skilled nursing revenue$373.74 $363.44 $337.13 $324.03 $336.18 $352.74 $365.45 $357.51 
(1) These rates exclude additional Federal Medical Assistance Percentage (FMAP) and include sequestration reversal of 1% for the second quarter in 2022 and 2% for the first quarter of 2022 and the six months ended June 30, 2021.
The following tables set forth our percentage of skilled nursing patient revenue and days by payor source for the three and six months ended June 30, 2022 and 2021:
 Three Months Ended June 30,
 Same FacilityTransitioningAcquisitionsTotal
 20222021202220212022202120222021
PERCENTAGE OF SKILLED NURSING REVENUE
Medicare24.3 %24.7 %24.7 %26.0 %22.9 %23.7 %24.2 %24.8 %
Managed care19.6 19.6 16.6 14.9 11.1 8.1 18.5 18.6 
Other skilled8.7 8.6 3.7 3.5 10.2 9.5 8.2 8.0 
Skilled mix52.6 52.9 45.0 44.4 44.2 41.3 50.9 51.4 
Private and other payors7.1 6.9 7.9 8.1 6.4 5.9 7.2 7.0 
Medicaid40.3 40.2 47.1 47.5 49.4 52.8 41.9 41.6 
TOTAL SKILLED NURSING100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %




 Three Months Ended June 30,
 Same FacilityTransitioningAcquisitionsTotal
 20222021202220212022202120222021
PERCENTAGE OF SKILLED NURSING DAYS
Medicare13.0 %12.8 %12.1 %12.2 %10.9 %10.9 %12.7 %12.6 %
Managed care14.0 13.8 11.7 10.1 7.3 5.1 13.1 13.0 
Other skilled5.6 5.7 2.6 2.6 7.0 5.8 5.3 5.3 
Skilled mix32.6 32.3 26.4 24.9 25.2 21.8 31.1 30.9 
Private and other payors10.5 10.4 11.5 10.9 8.5 7.2 10.5 10.3 
Medicaid56.9 57.3 62.1 64.2 66.3 71.0 58.4 58.8 
TOTAL SKILLED NURSING100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %

 Six Months Ended June 30,
 Same FacilityTransitioningAcquisitionsTotal
 20222021202220212022202120222021
PERCENTAGE OF SKILLED NURSING REVENUE
Medicare25.9 %26.9 %27.9 %29.4 %24.5 %29.4 %26.1 %27.3 %
Managed care19.7 19.4 16.2 14.7 11.7 7.4 18.6 18.5 
Other skilled8.5 8.3 3.6 3.0 9.5 12.3 7.9 7.7 
Skilled mix54.1 54.6 47.7 47.1 45.7 49.1 52.6 53.5 
Private and other payors6.9 6.5 7.6 7.5 6.0 4.6 7.0 6.5 
Medicaid39.0 38.9 44.7 45.4 48.3 46.3 40.4 40.0 
TOTAL SKILLED NURSING100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %

 Six Months Ended June 30,
 Same FacilityTransitioningAcquisitionsTotal
 20222021202220212022202120222021
PERCENTAGE OF SKILLED NURSING DAYS
Medicare14.0 %14.2 %13.7 %14.0 %11.9 %13.7 %13.8 %14.2 %
Managed care14.4 13.9 11.5 10.4 7.7 5.0 13.4 13.2 
Other skilled5.5 5.6 2.6 2.4 6.6 8.0 5.2 5.2 
Skilled mix33.9 33.7 27.8 26.8 26.2 26.7 32.4 32.6 
Private and other payors10.2 9.9 11.1 10.4 7.9 6.1 10.2 9.8 
Medicaid55.9 56.4 61.1 62.8 65.9 67.2 57.4 57.6 
TOTAL SKILLED NURSING100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %






THE ENSIGN GROUP, INC.
UNAUDITED REVENUE BY PAYOR SOURCE

The following table sets forth our service revenue by payor source and as a percentage of total service revenue for the periods indicated:
 Three Months Ended June 30,
20222021
Revenue% of RevenueRevenue% of Revenue
Medicaid(1)
$294,128 40.4 %$251,455 39.6 %
Medicare190,494 26.2 170,008 26.8 
Medicaid — skilled49,763 6.8 42,740 6.7 
Total Medicaid and Medicare534,385 73.4 464,203 73.1 
Managed care128,587 17.7 112,963 17.8 
Private and other(2)
65,375 8.9 57,443 9.1 
SERVICE REVENUE$728,347 100.0 %$634,609 100.0 %
(1) Medicaid payor includes revenue for senior living operations and revenue related to FMAP for the three months ended June 30, 2022 and 2021.
(2) Private and other payors also includes revenue from senior living operations and all payors generated in other ancillary services for the three months ended June 30, 2022 and 2021.
 Six Months Ended June 30,
20222021
Revenue% of RevenueRevenue% of Revenue
Medicaid(1)
$560,476 39.0 %$482,813 38.4 %
Medicare398,905 27.7 360,311 28.6 
Medicaid — skilled95,712 6.7 82,733 6.6 
Total Medicaid and Medicare1,055,093 73.4 925,857 73.6 
Managed care256,373 17.8 221,308 17.6 
Private and other(2)
126,037 8.8 110,720 8.8 
SERVICE REVENUE$1,437,503 100.0 %$1,257,885 100.0 %
(1) Medicaid payor includes revenue for senior living operations and revenue related to FMAP for the six months ended June 30, 2022 and 2021.
(2) Private and other payors also includes revenue from senior living operations and all payors generated in other ancillary services for the six months ended June 30, 2022 and 2021.

THE ENSIGN GROUP, INC.
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION BY SEGMENT
(In thousands)

Skilled Services

The table below reconciles net income to EBITDA and Adjusted EBITDA for the skilled services reportable segment for the periods presented:
Three Months Ended June 30,Six Months Ended June 30,
2022202120222021
Statements of Income Data:
Segment income(a)$102,266 $90,010 $200,522 $178,941 
Depreciation and amortization8,113 7,703 16,014 15,178 
EBITDA$110,379 $97,713 $216,536 $194,119 
Adjustments to EBITDA:
Stock-based compensation expense3,539 2,785 6,813 5,196 
ADJUSTED EBITDA$113,918 $100,498 $223,349 $199,315 
(a)    Segment income reflects profit or loss from operations before provision for income taxes and impairment charges from operations. General and administrative expenses are not allocated to the skilled services segment for purposes of determining segment profit or loss.



Standard Bearer
In conjunction with the formation Standard Bearer Healthcare REIT, Inc. (Standard Bearer) in January 2022, we revised our former real estate segment to include only real estate properties that are part of Standard Bearer. Segment information for the prior period has been recast to reflect the change of our segment structure. In addition, included in the results during the three and six months ended June 30, 2022 are expenses incurred related to intercompany arrangements between Standard Bearer and its subsidiaries and certain subsidiaries of the Company that were entered into in 2022 and therefore are not reflected in the 2021 amounts.
The following table sets forth details of operating results for our revenue and earnings, and their respective components, by Standard Bearer for the periods indicated:
 Three Months Ended June 30,Six Months Ended June 30,
2022202120222021
Rental revenue generated from third-party tenants$3,704 $3,430 $7,472 $6,908 
Rental revenue generated from Ensign affiliated operations13,894 10,784 27,319 21,375 
TOTAL RENTAL REVENUE$17,598 $14,214 $34,791 $28,283 
Segment income(a)6,838 7,906 13,738 15,619 
Depreciation and amortization5,216 4,248 10,237 8,403 
FFO(b)$12,054 $12,154 $23,975 $24,022 
(a) Segment income reflects profit or loss from operations before provision for income taxes, excluding gain or loss from sale of real estate and insurance recoveries from real estate. Included in Standard Bearer expenses for the three and six months ended June 30, 2022 are $3.0 million and $5.9 million in expenses, respectively, which includes management fee of $1.1 million and $2.1 million, respectively, and interest of $1.9 million and $3.8 million, respectively. The intercompany agreements between Standard Bearer and The Ensign Group, Inc. and other affiliated entities, including the Service Center, that were entered into in January 2022. These agreements were not in place in 2021, therefore no expense was recognized in 2021.

(b) FFO, in accordance with the definition used by the National Association of Real Estate Investment Trusts, means net income attributable to common stockholders, computed in accordance with U.S. GAAP, excluding gains (or losses) from sales of real estate and impairment of depreciable real estate assets, while including depreciation and amortization related to real estate to earnings.

Discussion of Non-GAAP Financial Measures

EBITDA consists of net income before (a) other expense, net, (b) provisions for income taxes and (c) depreciation and amortization. Adjusted EBITDA consists of net income before (a) other expense, net, (b) provisions for income taxes, (c) depreciation and amortization, (d) stock-based compensation expense; (e) results of operations not at full capacity, excluding depreciation, interest and income taxes, (f) acquisition related costs, new systems implementation costs and other costs, (g) legal finding and (h) gain on sale of assets. Adjusted EBITDAR consists of net income before (a) other expense, net, (b) provisions for income taxes, (c) depreciation and amortization, (d) rent-cost of services, (e) stock-based compensation expense; (f) results of operations not at full capacity, excluding rent, depreciation, interest and income taxes, (g) acquisition related costs acquisition related costs, new systems implementation costs and other costs, (h) legal finding, and (i) gain on sale of assets. Funds from Operations (FFO) for our real estate segment consists of segment income, excluding depreciation and amortization related to real estate, gains or losses from sales of real estate, insurance recoveries related to real estate and impairment of depreciable real estate assets. The company believes that the presentation of EBITDA, adjusted EBITDA, FFO, adjusted net income and adjusted earnings per share provides important supplemental information to management and investors to evaluate the company’s operating performance. Adjusted EBITDAR is a financial valuation measure that is not specified in GAAP. This measure is not displayed as a performance measure as it excludes rent expense, which is a normal and recurring operating expense. The company believes disclosure of adjusted net income, adjusted net income per share, FFO, EBITDA, adjusted EBITDA and adjusted EBITDAR has substance because the excluded revenues and expenses are infrequent in nature and are variable in nature, or do not represent current revenues or cash expenditures. A material limitation associated with the use of these measures as compared to the GAAP measures of net income and diluted earnings per share is that they may not be comparable with the calculation of net income and diluted earnings per share for other companies in the company's industry. These non-GAAP financial measures should not be relied upon to the exclusion of GAAP financial measures. For further information regarding why the company believes that this non-GAAP measures provide useful information to investors, the specific manner in which management uses these measures, and some of the limitations associated with the use of these measures, please refer to the company's periodic filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Report on Form 10-Q. The company’s periodic filings are available on the SEC's website at www.sec.gov or under the "Financial Information" link of the Investor Relations section on Ensign’s website at http://www.ensigngroup.net.

EX-101.SCH 3 ensg-20220801.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover Document link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 ensg-20220801_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Trading Symbol Trading Symbol Entity File Number Entity File Number Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Soliciting Material Soliciting Material Entity Address, City or Town Entity Address, City or Town Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Local Phone Number Local Phone Number Entity Address, Postal Zip Code Entity Address, Postal Zip Code Written Communications Written Communications City Area Code City Area Code Cover page. Cover [Abstract] Title of 12(b) Security Title of 12(b) Security Document Type Document Type Amendment Flag Amendment Flag Security Exchange Name Security Exchange Name Entity Registrant Name Entity Registrant Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Address, State or Province Entity Address, State or Province Document Period End Date Document Period End Date Pre-commencement Tender Offer Pre-commencement Tender Offer EX-101.PRE 5 ensg-20220801_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 6 ensigngrouplogoa02a01a34.gif GRAPHIC begin 644 ensigngrouplogoa02a01a34.gif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end XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.2
Cover Document
Aug. 01, 2022
Cover [Abstract]  
Document Type 8-K
Document Period End Date Aug. 01, 2022
Entity Registrant Name Ensign Group, Inc
Entity Incorporation, State or Country Code DE
Entity File Number 001-33757
Entity Tax Identification Number 33-0861263
Entity Address, Address Line One 29222 Rancho Viejo Road, Suite 127,
Entity Address, City or Town San Juan Capistrano,
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92675
City Area Code 949
Local Phone Number 487-9500
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol ENSG
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001125376
Amendment Flag false
XML 8 ensg-20220801_htm.xml IDEA: XBRL DOCUMENT 0001125376 2022-08-01 2022-08-01 0001125376 false 8-K 2022-08-01 Ensign Group, Inc DE 001-33757 33-0861263 29222 Rancho Viejo Road, Suite 127, San Juan Capistrano, CA 92675 949 487-9500 false false false false Common Stock, par value $0.001 per share ENSG NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2 html 1 22 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Document Sheet http://www.ensigngroup.net/role/CoverDocument Cover Document Cover 1 false false All Reports Book All Reports ensg-20220801.htm ensg-20220801.xsd ensg-20220801_lab.xml ensg-20220801_pre.xml q22022pressrelease.htm http://xbrl.sec.gov/dei/2022 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ensg-20220801.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "ensg-20220801.htm" ] }, "labelLink": { "local": [ "ensg-20220801_lab.xml" ] }, "presentationLink": { "local": [ "ensg-20220801_pre.xml" ] }, "schema": { "local": [ "ensg-20220801.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "ensg", "nsuri": "http://www.ensigngroup.net/20220801", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ensg-20220801.htm", "contextRef": "i964dff4304a34b569e9d304f5244ad96_D20220801-20220801", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover Document", "role": "http://www.ensigngroup.net/role/CoverDocument", "shortName": "Cover Document", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ensg-20220801.htm", "contextRef": "i964dff4304a34b569e9d304f5244ad96_D20220801-20220801", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 15 0001125376-22-000115-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001125376-22-000115-xbrl.zip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